| Enoch Kotei, MD | |
|
2084 Headland Dr, East Point, GA 30344 | |
| (404) 965-5691 | |
| (404) 698-1478 |
| Full Name | Enoch Kotei |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 2084 Headland Dr, East Point, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205179512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 73541 (Georgia) | Primary |
| Entity Name | Southside Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235123993 PECOS PAC ID: 6901700723 Enrollment ID: O20031212000357 |
News Archive
Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
For patients with myelodysplastic syndromes (MDS), choosing the appropriate treatment depends heavily on the prognosis. Those patients at the highest risk of dying from their disease are typically offered the most aggressive therapies, while patients at lower risk could live several years with MDS, needing only supportive care or other relatively side-effect free treatments.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Miltenyi Biotec announced today that the U.S. Food and Drug Administration has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.
› Verified 8 days ago
| Entity Name | Pmr Georgia Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609329630 PECOS PAC ID: 8426466590 Enrollment ID: O20210409002172 |
News Archive
Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
For patients with myelodysplastic syndromes (MDS), choosing the appropriate treatment depends heavily on the prognosis. Those patients at the highest risk of dying from their disease are typically offered the most aggressive therapies, while patients at lower risk could live several years with MDS, needing only supportive care or other relatively side-effect free treatments.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Miltenyi Biotec announced today that the U.S. Food and Drug Administration has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Enoch Kotei, MD 1395 Nw 167th St, Miami Gardens, FL 33169-5710 Ph: (305) 628-6117 | Enoch Kotei, MD 2084 Headland Dr, East Point, GA 30344 Ph: (404) 965-5691 |
News Archive
Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
For patients with myelodysplastic syndromes (MDS), choosing the appropriate treatment depends heavily on the prognosis. Those patients at the highest risk of dying from their disease are typically offered the most aggressive therapies, while patients at lower risk could live several years with MDS, needing only supportive care or other relatively side-effect free treatments.
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Miltenyi Biotec announced today that the U.S. Food and Drug Administration has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.
› Verified 8 days ago
Dr. Yssa Saaddine, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Ave, Ste 209, East Point, GA 30344 Phone: 404-762-8211 Fax: 404-762-9182 | |
Charles N. Okolo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1151 Cleveland Ave, Suite D, East Point, GA 30344 Phone: 404-761-7949 Fax: 404-761-7386 | |
Dr. Legesse F. Tebeje, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1170 Cleveland Ave, East Point, GA 30344 Phone: 404-466-1170 | |
Austin Campbell Gitomer, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2084 Headland Dr, East Point, GA 30344 Phone: 404-965-5691 Fax: 404-698-1478 | |
Dr. Fawaz F Akbik, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Ave, Ste 519, East Point, GA 30344 Phone: 404-761-3525 Fax: 404-766-3696 | |
Ngozika A Orjioke, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Ave Ste 615, East Point, GA 30344 Phone: 404-254-5388 Fax: 404-565-1255 |